🔥 MAGA Cannabis War Erupts + SAM’s Cold Leftovers

Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.

Before diving into today's intelligence, we want to thank our sponsor 1440 Media for supporting today’s edition. Our sponsors support the free distribution of this service. Interested in seeing your brand featured in a future policy brief? Reach out!

While Trump weighs his cannabis decision “over the next few weeks,” his coalition is fracturing in real time over rescheduling. MAGA influencers are openly warring with traditional conservatives and SAM published their most recent panic attack in The Daily Caller. Meanwhile, states from Rhode Island to Minnesota and Florida are all making moves to continue regulating their markets while simultaneously monitoring federal winds. Today’s intelligence covers the strategic implications of a conservative movement eating itself over cannabis policy, plus critical state developments positioning for federal reform.

👀 Keep an eye on DC and at home.

🐟 Don’t believe everything you read (from SAM).

🧠 Stay calm. Stay compliant.

Start smarter. Move faster. Stay ahead.

📌 What Happened: Trump's confirmation Monday that he'll decide on marijuana rescheduling "over the next few weeks" has triggered open warfare within MAGA ranks, with prominent conservative voices launching scathing attacks on cannabis reform while libertarian allies defend it as anti-establishment medicine. Daily Wire's Matt Walsh declared that "no country of potheads has ever thrived" and "every city that legalized it became an even bigger sh*thole basically overnight," while MAGA podcaster Jack Posobiec complained he doesn't "want to have to be smelling weed anytime I take my kids anywhere in a city or a national park." The backlash includes Breaking Points host Saagar Enjeti warning that "marijuana mass normalization has been a disaster" causing cities to "stink" and making kids "literally poisoned and stupid," while conservative commentator Steve Cortes called weed "a scourge" that saps "productivity of far too many citizens, especially young men." However, MAGA influencer Rogan O'Handley countered that rescheduling would hurt "Big Pharma" and "Big Prison," while CJ Pearson framed Trump's consideration as supporting veterans whose "lives have been changed for the better by its medicinal benefits."

💡 Why It Matters: The intra-MAGA cannabis civil war exposes fundamental cultural tensions within Trump's coalition between traditionalist purists who view marijuana as incompatible with masculine virtue and libertarian pragmatists who see prohibition as government overreach. The opposition reflects MAGA's rigid definition of "Western civilization" and stoic masculinity, with podcaster Michael Knowles arguing conservatives prefer "traditional pleasures" like whiskey and cigars over what he calls the "liberal intoxicant of choice" that promotes sloth. The split forces Trump to navigate between satisfying cannabis industry donors who contributed millions to his political groups and appeasing movement ideologues who view any liberalization as cultural surrender. The debate reveals how policy positions become identity markers within populist movements, where cultural symbolism often trumps economic pragmatism and even medical necessity arguments.

🎪 SAM's Death Rattle: Prohibitionists Serve Cold Leftovers to Trump

Smart Approaches to Marijuana's Luke Niforatos just published the policy equivalent of microwaved fish in The Daily Caller - technically edible, but nobody asked for it and it stinks up the room. His breathless warning to Trump about cannabis rescheduling reads like a prohibition greatest hits album, complete with debunked studies about "cardiovascular death" and theatrical warnings about Mexican cartels infiltrating your local dispensary. The piece is so desperate it cites Pennsylvania doctors issuing medical marijuana cards as evidence of abuse…apparently helping patients is now suspicious behavior. Niforatos even claims HHS "put politics before science" in recommending rescheduling, which is rich coming from an organization whose entire existence depends on ignoring the scientific consensus on cannabis. When your opposition is reduced to arguing that FDA-approved cannabinoid medications somehow prove marijuana has no medical use, you know they're not sending their best people. With Trump privately committed to rescheduling according to multiple industry sources and 90% of public comments supporting reform, SAM's tantrum signals one thing: the prohibition gravy train is approaching its final station, and the conductors are frantically throwing furniture off the caboose. (Daily Caller)

🚔 Rhode Island Revokes Cannabis License After Founder Caught Fleeing with 250 Pounds

Building on our Sidebar from earlier this week about Rhode Island's Cannabis Control Commission revoking THCBD LLC's cultivation license, new details reveal founder Anthony Walker was arrested attempting to flee with over 250 pounds of marijuana when state inspectors arrived to oversee court-ordered destruction of remaining inventory. The Hopkinton-based cultivator's dramatic collapse included Walker's foot chase into the woods, felony possession charges, and inspectors discovering bags of untagged cannabis hidden in ceiling and attic spaces above the facility's break room. THCBD faced repeated violations since 2021 including disabled surveillance systems, missing compliance officers, inaccurate inventory tracking, and $800,000 in unpaid penalties before the spectacular compliance breakdown that ended with criminal charges. The case highlights regulatory capture risks as THCBD had partnered with rapper Method Man's TICAL brand in 2023, marketed as collaboration with one of the state's "premier Black cultivators" before the compliance failures emerged. Chairwoman Kimberly Ahern called the revocation a message that violations "won't be accepted, condoned or tolerated" as Rhode Island's Cannabis Office flexes enforcement muscle in its first major action since assuming oversight from the Department of Business Regulation in May. (Providence Business News)

🛒 Minnesota Retailers Get Licenses But Still Can't Source Products

Minnesota's Office of Cannabis Management has granted final approval to five retail dispensaries in July, marking the first non-tribal cannabis stores in the state, but these retailers face a critical supply problem with only two cultivation centers receiving licenses so far. Interim Director Eric Taubel predicts up to 150 marijuana businesses could open by year-end, but the regulatory structure created a timing mismatch where retailers receive approval before adequate cultivation infrastructure exists to supply inventory. The state's complex licensing process included lawsuits, disqualifications, and delays that pushed retail launch from early 2025 into summer, while tribal operations have been selling cannabis on reservations since legalization in August 2023. Minnesota's unique regulatory model prioritized social equity through a lottery system reserving 50% of licenses for affected communities, but the sequential rollout means retailers like The Smoking Tree in Albert Lea and MN Loon dispensary in Minneapolis must wait for cultivation partners to scale production. The supply shortage illustrates common pitfalls in cannabis market launches where regulatory complexity creates artificial bottlenecks that benefit existing operators while leaving new licensees with storefronts but empty shelves. Governor Tim Walz recently called cannabis implementation the most difficult 2023 law to execute, highlighting how well-intentioned equity programs can create operational dysfunction when licensing timelines don't align with market realities. (MinnPost, MPR News)

🧠 Maryland Psychedelics Task Force Struggles to Find Opposition to Legalization Framework

Maryland's 17-person psychedelics task force has reached consensus supporting regulated frameworks for psilocybin, mescaline, and DMT despite intensive outreach to find opponents, with members reporting they "cannot find opposition" even from expected skeptical voices like law enforcement representatives who instead highlighted therapeutic benefits for officers with PTSD. The task force completed over 100 meetings representing 500+ volunteer hours and developed 85 potential recommendations covering medical use, commercial sales, and supervised adult use, but chair Andrew Coop warns they're struggling to avoid appearing as "cheerleaders" without meaningful opposition input. The panel explicitly "does not support delaying state action pending future FDA approval," positioning Maryland for potential first-mover advantages in psychedelics regulation similar to early cannabis legalization states. The absence of organized opposition suggests psychedelics policy faces dramatically different political dynamics than cannabis, with therapeutic applications creating broad coalition support that transcends traditional ideological divisions. Final recommendations due October 30 will be forwarded to the legislature, setting up Maryland as a potential catalyst for East Coast psychedelics policy while other states watch implementation models emerge. (Marijuana Moment)

📋 Florida Cannabis Petition Campaign Challenges Restrictive Ballot Initiative Law

Smart and Safe Florida joined a federal lawsuit challenging Florida's HB 1205, which tightened ballot initiative rules by shortening petition submission deadlines from 30 to 10 days and restricting unregistered signature gatherers to 25 petitions each, with violations now classified as felonies. The campaign argues the law "changes the rules at halftime" for groups already collecting signatures for 2026 ballot initiatives, with attorneys calling the restrictions "gaslighting" that imposes "unconstitutional barriers" to First Amendment petition rights. U.S. District Judge Mark Walker already granted a preliminary injunction blocking provisions that disallow nonresidents and noncitizens from circulating petitions, finding them unconstitutional under free speech protections. Smart and Safe Florida reports collecting over 613,000 verified signatures toward the 880,000 needed for 2026 ballot placement, while simultaneously launching a second initiative allowing medical patients to grow cannabis at home. The legal challenge highlights how states weaponize ballot access restrictions to thwart citizen initiatives, with Florida's Republican legislature enacting deliberate obstacles after Amendment 3 received 56% support in 2024 but fell short of the required 60% supermajority. The case demonstrates broader tensions between legislative hostility toward cannabis reform and constitutional protections for citizen petitioning rights. (WUSF, Yahoo News)

🏛️ Braun Says Trump Rescheduling Could Add "Fuel to Fire" for Indiana Cannabis Reform

Indiana Governor Mike Braun acknowledged that Trump's federal marijuana rescheduling review could accelerate cannabis legalization momentum in his state, saying it "probably adds a little more fuel to the fire in terms of the speed with which it might occur." Braun's comments signal potential GOP evolution on cannabis policy as Indiana remains increasingly isolated with all four neighboring states having legalized some form of cannabis while the Hoosier state maintains total prohibition. The governor continues to defer to law enforcement views on policy changes but noted that "winds have shifted" over recent years, with cannabis reform gaining traction within Indiana's Republican party through lobbying efforts and bipartisan legislative proposals. Despite 87% public support for medical marijuana and record legislative activity this session with eight cannabis bills introduced, Republican leadership killed all reform efforts with leaders citing safety concerns and rejecting revenue-based policy arguments. Trump's federal rescheduling timeline creates new political pressure on prohibition holdouts like Indiana, where the disconnect between a Republican president reconsidering cannabis policy and state GOP leadership maintaining criminalization becomes increasingly difficult to explain. Braun's acknowledgment that federal action could accelerate state-level change suggests growing recognition that Indiana's prohibition island position is becoming politically and economically unsustainable as neighboring markets generate revenue and federal policy potentially liberalizes. (Indianapolis Star)

🎯 Matt Gaetz Warns Democrats: Trump Rescheduling Cannabis Means "Game Over at Ballot Box"

Former Rep. Matt Gaetz, Trump's scandal-plagued original AG pick who withdrew amid ethics controversies, dedicated significant airtime Monday to urging cannabis rescheduling with his signature theatrical flair, declaring "if President Trump does this, the game is over for Democrats at the ballot box" through cringe-worthy populist messaging envisioning "MAGA hats in line at the dispensary, patriots buying prerolls called '1776 Freedom Kush.'" Gaetz's performative commentary mocks current federal policy treating marijuana "just as bad as heroin and somehow worse than fentanyl" while positioning Republicans as competent governance champions who can "fix this ridiculous policy the swamp ignored for half a century." The former congressman's theatrical advocacy comes as Trump faces timeline pressure after promising a rescheduling decision "within weeks," with bipartisan congressional lawmakers and a political committee sharing the same treasurer as Trump's MAGA super PAC applying genuine pressure for action. Despite Gaetz's bombastic delivery and questionable credibility, his political calculation reflects sophisticated understanding that cannabis reform cuts across traditional partisan lines, potentially neutralizing a Democratic advantage while appealing to younger voters and suburban moderates without alienating core Republican support through careful medical-focused framing. The spectacle demonstrates how even disgraced political figures recognize cannabis policy's electoral potency in reshaping traditional coalition dynamics. (Marijuana Moment)

💊 Pharmacists Position for Central Role in Post-Rescheduling Cannabis Distribution

Schedule III rescheduling could place pharmacists at the center of medical cannabis distribution through two potential pathways: pharmaceutical companies submitting investigational new drug applications for standardized cannabinoid products, or implementing 21 CFR § 1306.26 allowing pharmacists to obtain and dispense tested cannabis materials with enhanced training requirements. The pharmaceutical route requires decade-long clinical trials while the regulatory pathway needs only increased pharmacist education on proper sourcing, potential compounding, and safe dosing protocols for products with varying THC, CBD, and minor cannabinoid concentrations. Drug Topics emphasizes pharmacists' unique qualifications to assess cannabis risks including cardiovascular complications, liver metabolism through CYP enzymes, drug interactions, and cannabis use disorder potential while helping patients navigate diverse formulations from tablets to topicals. The analysis assumes federal rescheduling creates immediate pharmacy access, but overlooks state-federal regulatory conflicts where existing dispensary systems may resist pharmaceutical channel integration. Rescheduling transforms pharmacists from prohibition enforcers to cannabis therapy experts, positioning them to capture significant market share from current dispensary models through superior clinical expertise and insurance integration capabilities. The pharmaceutical industry's interest in standardized products versus patient preference for diverse cannabis varieties could create tension over product availability and therapeutic options. (Drug Topics)

🥤 Hemp Beverage Gold Rush Exploits Regulatory Loophole Before Inevitable Correction

The hemp beverage explosion reveals how poorly crafted legislation creates billion-dollar arbitrage opportunities that sophisticated operators exploit before inevitable regulatory correction. Cannabis journalist Jackie Bryant's assessment of the 2018 Farm Bill's "dry weight" provision as a "poorly written law" understates the policy failure that allows companies to pack over 1,000 milligrams of THC into beverages while meeting the 0.3% threshold on paper. This regulatory accident has transformed hemp from agricultural commodity into a $3.09 billion intoxicating beverage category projected to hit $117 billion by 2032, with brands flooding mainstream retail channels that remain off-limits to traditional cannabis operators. The geographic concentration in prohibition states like North Carolina, Florida, and Texas demonstrates how hemp beverages function as pressure release valves for cannabis demand in markets where political opposition prevents proper legalization. While industry marketing promises canna-curious newcomers, the reality shows experienced cannabis consumers driving sales as they exploit the only legal THC access point available outside dispensary systems. The alcohol industry's evolving response from fear to participation signals recognition that hemp beverages represent temporary regulatory arbitrage rather than permanent market disruption, with distributors signing brands and Constellation Brands weighing entry before federal rescheduling eliminates the loophole entirely. (VinePair)

🧾 Context: The U.S. Court of Appeals for the Second Circuit struck down New York's cannabis licensing preference for applicants with in-state convictions, ruling that prioritizing New York-specific criminal histories violates the dormant Commerce Clause despite the program's social equity objectives. The decision reverses a lower court that found the Commerce Clause inapplicable to federally illegal markets, with the appeals court declaring that "Congress has given New York no clear permission to favor its residents over others whose businesses skirt the federal drug laws." This represents the latest in a series of federal court victories against state cannabis residency requirements, following similar rulings in Maine, Missouri, and Michigan that have systematically dismantled local preference programs. The case was brought by California-owned Variscite entities seeking New York dispensary licenses, demonstrating how out-of-state capital leverages constitutional doctrine to challenge community-focused regulations.

🔎 What It Signals: The ruling establishes that dormant Commerce Clause protections apply fully to state cannabis markets despite federal prohibition, creating a constitutional framework that favors interstate capital over local equity priorities. Senior Judge Dennis Jacobs emphasized that Congress must "clearly authorize" exceptions to commerce protections, finding no such authorization in federal cannabis criminalization despite the paradox that federal law prohibits the very markets states are now required to open to interstate competition. Chief Judge Debra Ann Livingston's partial dissent reveals judicial uncertainty about requiring states to "promote the very interstate commerce Congress wants to eradicate," but the majority opinion prioritizes constitutional formalism over practical policy considerations. The decision threatens social equity programs nationwide by establishing that geographic-based preferences constitute impermissible protectionism, regardless of restorative justice rationales or efforts to remedy local enforcement disparities.